INTERVENTIONAL ONCOLOGY SANS FRONTIERES (IOSF) CONGRESS 2016
and 1st World Congress on FUSION IMAGING and AUGMENTED REALITY for Interventional Procedures
Download Program
ORGANIZING and SCIENTIFIC COMMITTEE
Luigi Solbiati
S. Nahum Goldberg
Franco Orsi
Fusion Imaging and Augmented Reality
SCIENTIFIC COMMITTEE
Giovanni Mauri
Anastasios Michos
Francesco DiMeco
Francesco Prada
Guido Torzilli
Thursday, July 7
08:15 – 08:40
REGISTRATION
08:40 – 09:00
Welcome and Introduction
Organizing Committee - Giovanni Cerri
09:00 – 09:20
KEYNOTE LECTURE:
20 years of ablation: Past, present and future
20 years of ablation: Past, present and future
Steve Solomon
STATE-OF-ART of TECHNOLOGY
IMAGING
09:25 – 09:40
Cone beam technology: How did we ever work without it?
Marco van Strijen
09:40 – 09:55
CEUS for the guidance of thermal ablation: Current reliability and advancements
Ernst-Michael Jung
09:55 – 10:10
CEUS and TAE/TACE: A new “marriage”
Dario Poretti
10:10 – 10:20
Real-time ablation monitoring: Elastosonography makes the dream come true
Laura Crocetti
10:20 – 10:35
MRI for guidance: How do I justify it?
Philippe Pereira
10:35 – 10:50
Imaging and follow-up: When and how?
Thomas Helmberger
10:50 – 11:00
DISCUSSION
11:00 – 11:10
Coffee break
11:10– 11:30
KEYNOTE LECTURE:
Cancer stem cells as a target for therapeutic intervention in cancer
Cancer stem cells as a target for therapeutic intervention in cancer
Salvatore Pece
ABLATION
11:30 – 12:00
RF vs MW: How do I choose?
*MW: In 2016 it’s the only way to go
Franca Meloni
*But I still love using Radiofrequency
Alice Gillams
12:00 – 12:15
Microwave ablation – Is it living up to the hype?
J. Louis Hinshaw
12:15 – 12:30
Irreversible electroporation: State of the art
Govindarajan Narayanan
12:30 – 12:45
HIFU: State of the art
Franco Orsi
12:45 – 12:50
DISCUSSION
12:50 – 13:10
KEYNOTE LECTURE:
Systemic effects of ablation
Systemic effects of ablation
S. Nahum Goldberg
13:10 – 14:00
Lunch
1st WORLD MEETING on FUSION IMAGING and AUGMENTED REALITY
for INTERVENTIONAL PROCEDURES
FUSION IMAGING and NAVIGATION in INTERVENTIONAL ONCOLOGY
14:00 – 14:20
Navigation tools: An overview
Brad Wood
14:20 – 15:10
Are they really useful for liver ablations?
*The Italian experience
Giovanni Mauri
*The European experience
Anastasios Michos
*The Chinese experience
Liang Ping
*The Korean experience (S-Fusion)
Min Woo Lee
15:10 – 15:35
Extrahepatic applications
*Virtual Navigation: Prostate, lung and neck
Giancarlo Bizzarri
*Prostate interventions with irreversible electroporation
Thomas Fischer
15:35 – 15:45
Where will Fusion Imaging and Navigation be in 3 years?
Luigi Solbiati
15:45 – 15:55
DISCUSSION
15:55 – 16:15
Coffee break
FUSION IMAGING and NAVIGATION in NEUROSURGERY
16:15 – 16:30
Multimodal visualisation in interventional procedures
Tormod Selbekk
16:30 – 16:45
Fusion imaging in neurosurgery
Francesco Prada
16:45 – 17:00
3D navigated ultrasound
Andrej Steno
FUSION IMAGING and NAVIGATION in ABDOMINAL SURGERY
Chairmen: Kiyoshi Hasegawa – Guido Torzilli
17:05 – 17:20
Fusion imaging and fluorence for strategic surgical planning
Kiyoshi Hasegawa
17:20 – 17:35
Fusion imaging for surgical management of colorectal liver metastases
Guido Torzilli
17:35 – 17:50
Fusion imaging as a tool for facilitating surgeons’ training in intraoperative navigation
Matteo Donadon
THE FUTURE: INTEGRATED MULTIMODAL IMAGING, AUGMENTED REALITY AND NOVEL PARADIGMS FOR INTERVENTIONAL TRAINING
17:55 – 18:10
The AMIGO suite: A surgical innovation laboratory
Alexandra Golby
18:10 – 18:50
- Intra-operative US simulation for neurosurgical training
Curzio Basso
- Simulation techniques: From high-tech aviation to high-risk surgery
Alex Lever
- New candidates' selection and teaching paradigms in neurosurgery: Preliminary experience at the Besta NeuroSim Center
Alessandro Perin
18:50 – 19:00
DISCUSSION and CONCLUSIONS
Friday, July 8
CUTTING EDGE I O PRACTICE BY ORGAN SYSTEM: Part 1
-HCC: 20 years of thermal ablation
08:30 – 08:45
RFA: Results and lessons learned
Shuichiro Shiina
08:45 – 09:00
RFA: Still relevant for HCC?
Hyunchul Rhim
09:00 – 09:10
Can we raise the bar using Microwaves?
Franca Meloni – Luigi Solbiati
09:10 – 09:25
Ablation for intermediate HCC: extending BCLC guidelines
Reto Bale
09:25 – 09:40
Is BCLC therapeutic flow-chart still applicable?
Philippe Pereira
09:40 – 09:55
I O treatments in a Transplant Center
Umberto Cillo
09:55 – 10:10
Evolving role of combination therapies
S. Nahum Goldberg
10:10 – 10:20
DISCUSSION
- HEPATIC COLORECTAL METASTASES
10:20 – 10:35
Conservative ablation
Constantinos Sofocleous
10:35 – 10:50
Aggressive ablation
Alice Gillams
10:50 – 11:05
Stereotactic body radiation therapy vs ablation
Marta Scorsetti
11:05 – 11:15
DISCUSSION
11:15 – 11:35
Coffee break
- LUNG
11:35 – 11:50
We can do quite a bit with ablation
Steve Solomon
11:50 – 12:05
We can do even better adding chemoembolization
Cosmo Gadaleta
12:05 – 12:20
Radiation therapy is just fine, thank you
Marta Scorsetti
12:20 – 12:30
DISCUSSION
12:50 – 13:40
Lunch Satellite Symposium HOSPITAL SERVICE
Next generation HS AMICA: the new ablation paradigm
- The HS AMICA revolution: higher power, enhanced control, extended usability
Nevio Tosoratti
- Ablavision: taking ablation to a higher standard through pre- and post- treatment image processing
Marco Solbiati
13:40 – 14:00
KEYNOTE LECTURE:
TAE or TACE? The ultimate answer!
TAE or TACE? The ultimate answer!
Karen Brown
THE ARTERIAL ROUTE TO THE TUMOR
- HCC
14:00 – 14:15
Conventional TACE: Why Asia does it better?
Yasuaki Arai
14:15 – 14:30
TACE 2.0: Eluting beads: The first generation
Katerina Malagari
14:30 – 14:45
TACE 2.0: Eluting beads: The latest!
Goetz M.Richter
14:45 – 15:00
Beyond TACE: Do degradable starch microspheres put everything at stake?
Philippe Pereira
15:00 – 15:10
DISCUSSION
- RADIOEMBOLIZATION
15:10 – 15:30
Y90RE or TACE: That is the question
Robert Lewandowski
15:30 – 15:45
Do it superselectively or don’t bother
Roberto Cianni
15:45 – 16:00
What’s new? Lobar hypertrophy
Robert Lewandowski
16:00 – 16:10
DISCUSSION
16:10 – 16:30
Coffee break
- METASTATIC LIVER
16:30 – 16:45
The DEBIRI affair: What you should know
Camillo Aliberti
16:45 – 16:55
Integration of SIR-Spheres Y-90 resin microspheres into the management of colorectal metastases
Jens Ricke
16:55 – 17:10
Percutaneous hepatic chemoperfusion: Still alive?
Mark Burgmans
17:10 – 17:25
NET: The essential role of interventional radiologists
Thierry de Baere
17:25 – 17:35
The “Humanitas protocol” for treatment of recurrence of mCRC after resection
Luca Viganò
17:35 – 17:45
DISCUSSION
17:45 – 18:25
GOLD MEDAL PRESENTATIONS HONORING SEMINAL CONTRIBUTIONS TO INTERVENTIONAL ONCOLOGY :
Italy: Tito Livraghi
United States: William Charboneau
China: Min-Hua Chen
Social Dinner
Saturday, July 9
CUTTING EDGE I.O. PRACTICE BY ORGAN SYSTEM: Part 2
- KIDNEY and ADRENAL
08:45 – 09:00
20 years of RFA for renal cell carcinoma: Results and lessons learned
Franco Orsi
09:00 – 09:15
Renal mass ablation: What is the case for cryo?
David Breen
09:15 – 09:30
Interventional Oncology for kidney familial disease
Brad Wood
09:30 – 09:45
When to treat the adrenal gland
Muneeb Ahmed
09:45 – 10:00
DISCUSSION
10:00 – 10:20
KEYNOTE LECTURE: Mechanistic basis for improved TACE techniques
Jeff Geschwind
10:20 – 10:40
Coffee break
- OTHER ORGANS
10:40 – 11:00
What is the best way to ablate bone tumors?
Roberto L. Cazzato
11:00 – 11:20
Expanding the role of I O in musculoskeletal procedures
Alexis Kelekis
11:20 – 11:40
Breast cancer and ablation: What is the evidence?
Francesco Sardanelli
11:40 – 12:00
Ablation of thyroid cancers and cervical malignant adenopathies
Jung Hwan Baek
12:00 – 12:15
DISCUSSION
12:15 – 12:35
KEYNOTE LECTURE:
Debunking current myths in clinical trial design: Points of consideration for Interventional Radiology
Debunking current myths in clinical trial design: Points of consideration for Interventional Radiology
Riad Salem
12:35 – 13:50
Lunch
13:50 – 15:00
7 BEST ABSTRACTS (7 min + 3 min DISCUSSION)
15:00 – 16:00
CLINICAL PEARLS
Muneeb Ahmed, Yasuaki Arai, Thomas Helmberger
16:00 – 16:50
CASES I WISH I DID DIFFERENTLY
Roberto L. Cazzato, Thierry de Baere, Govindarajan Narayanan
16:50 – 17:00
CONCLUSIONS